Ayse Feyda Nursal1, Serbulent Yigit2, Ercan Tural3, Goknur Kalkan4, Mehmet Kemal Tumer5, Akin Tekcan6. 1. Department of Medical Genetics, Faculty of Medicine, Hitit University, Corum, Turkey. 2. Department of Medical Biology, Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey. 3. Havza Vocational School, Department of Physiotherapy Programme, Ondokuz Mayis University, Samsun, Turkey. 4. Department of Dermatology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey. 5. Department of Maxillofacial Surgery, Faculty of Dentistry, Gaziosmanpasa University, Tokat, Turkey. 6. Department of Medical Biology, Faculty of Medicine, Ahi Evran University, Kirsehir, Turkey.
Abstract
OBJECTIVE: The aim of the present study was to investigate any possible association between the macrophage migration inhibitory factor (MIF) -173GC variant and Behçet's disease (BD) in a group of Turkish patients. SUBJECTS AND METHODS: A total of 111 patients with BD and 100 healthy controls were enrolled in this study. Genomic DNA was extracted from peripheral lymphocytes. The MIF -173GC variant was genotyped using polymerase chain reaction restriction fragment length polymorphism. The allele and genotype frequencies of patients and controls were compared using the χ2 test. RESULTS: A statistically significant difference in the distribution of the genotype was observed between BD patients and healthy controls. The homo-genotype CC was more prevalent in the patient group compared to the control group (p = 0.008, OR: 0.24, 95% Cl: 0.05-0.78). A significant association was observed when the patients were compared with the controls according to GG + GC versus CC ge-notypes (p = 0.003, OR: 1.21, 95% CI: 0.06-0.063). Allele frequencies of the MIF -173GC variant did not show any statistically significant difference between patients and controls. CONCLUSION: In this study, we conclude that the CC ge-notype of the MIF -173GC variant may be a risk factor in the pathogenesis of BD in the Turkish population. However, further studies with larger samples are needed to address the exact role of this variant in BD.
OBJECTIVE: The aim of the present study was to investigate any possible association between the macrophage migration inhibitory factor (MIF) -173GC variant and Behçet's disease (BD) in a group of Turkish patients. SUBJECTS AND METHODS: A total of 111 patients with BD and 100 healthy controls were enrolled in this study. Genomic DNA was extracted from peripheral lymphocytes. The MIF -173GC variant was genotyped using polymerase chain reaction restriction fragment length polymorphism. The allele and genotype frequencies of patients and controls were compared using the χ2 test. RESULTS: A statistically significant difference in the distribution of the genotype was observed between BD patients and healthy controls. The homo-genotype CC was more prevalent in the patient group compared to the control group (p = 0.008, OR: 0.24, 95% Cl: 0.05-0.78). A significant association was observed when the patients were compared with the controls according to GG + GC versus CC ge-notypes (p = 0.003, OR: 1.21, 95% CI: 0.06-0.063). Allele frequencies of the MIF -173GC variant did not show any statistically significant difference between patients and controls. CONCLUSION: In this study, we conclude that the CC ge-notype of the MIF -173GC variant may be a risk factor in the pathogenesis of BD in the Turkish population. However, further studies with larger samples are needed to address the exact role of this variant in BD.
Authors: B Vozarova; N Stefan; R Hanson; R S Lindsay; C Bogardus; P A Tataranni; C Metz; R Bucala Journal: Diabetologia Date: 2002-11-16 Impact factor: 10.122
Authors: G Serarslan; S Söğüt; Z Yönden; H Oksüz; N Savas; J Z Yenin; A Arpaci Journal: J Eur Acad Dermatol Venereol Date: 2009-04-02 Impact factor: 6.166
Authors: Mara Anaís Llamas-Covarrubias; Yeminia Valle; Rosa Elena Navarro-Hernández; Iris Paola Guzmán-Guzmán; María Guadalupe Ramírez-Dueñas; Héctor Rangel-Villalobos; Ciro Estrada-Chávez; José Francisco Muñoz-Valle Journal: Rheumatol Int Date: 2011-05-24 Impact factor: 2.631
Authors: Fang-Fang Wang; Xin-Fang Huang; Nan Shen; Lin Leng; Richard Bucala; Shun-Le Chen; Liang-Jing Lu Journal: Arthritis Res Ther Date: 2013 Impact factor: 5.156